Home / Health / India's HPV Jab for 1.15 Cr Girls: Cervical Cancer Fight!
India's HPV Jab for 1.15 Cr Girls: Cervical Cancer Fight!
28 May
Summary
- India faces 25% of global cervical cancer deaths.
- Nationwide HPV vaccination for 1.15 crore girls began in Feb 2026.
- Portable PCR tests promise advanced screening accessible everywhere.
Globally, cervical cancer remains a significant threat, causing 660,000 cases and 350,000 deaths in 2022 alone. India tragically bears a substantial burden, accounting for 25% of these deaths with 120,000 cases and 80,000 fatalities. To combat this, India initiated a nationwide HPV vaccination program in February 2026, targeting free vaccination for approximately 1.15 crore girls aged 14.
This primary prevention strategy is vital, aligning with the WHO's goal of 90% HPV vaccination coverage. However, to achieve elimination, vaccination must be paired with robust screening. Molecular screening using PCR-based methods offers superior accuracy and earlier detection compared to traditional Pap smears or visual inspection.
Recent technological advancements have made portable PCR platforms feasible, enabling rapid, accurate HPV testing even in remote areas. This innovation is key to extending screening reach and fulfilling India's commitment to eradicating cervical cancer through a dual approach of vaccination and accessible screening for all women.
